http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109680064-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2019-01-17^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-22^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-22^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109680064-B |
| titleOfInvention | Application of YTHDF2 gene in diagnosis, prevention and treatment of urothelial cancer |
| abstract | The invention discloses application of YTHDF2 gene in diagnosis, prevention and treatment of urothelial cancer. The invention discloses application of a reagent for detecting YTHDF2 gene in preparation of a product for diagnosing urothelial cancer, and also discloses application of an inhibitor expressed by YTHDF2 gene in preparation of a medicament for treating or preventing urothelial cancer. The invention confirms the effect of YTHDF2 in urothelial cancer for the first time, YTHDF2 is up-regulated in the urothelial cancer tissue, and promotes the proliferation and migration capacity of urothelial cancer cells, YTHDF2 can be used as a potential target spot for clinical diagnosis and treatment of the urothelial cancer. |
| priorityDate | 2019-01-17^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 405 of 405.